BMS-599626
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS-599626, covering 2010-03-02 to 2012-10-04. Get the full timeline:
Most recent: Clinical Trial Update: BMS-599626 in Treating Patients With Metastatic Solid Tumors [Phase 1]